Organon & Co. (OGN) Social Stream
ORGANON & CO (OGN) Price Targets From Analysts
Use the tables below to see what analysts covering ORGANON & CO think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-12 | 7 | $48.001 | $35 | $39.833 | $16.83 | 136.68% |
| 2021-11-11 | 7 | $48.001 | $35 | $39.2 | $16.83 | 132.92% |
| 2021-12-15 | 7 | $48 | $35 | $39.2 | $16.83 | 132.92% |
| 2022-01-13 | 7 | $48 | $35 | $39 | $16.83 | 131.73% |
| 2022-02-07 | 7 | $46 | $35 | $38.666 | $16.83 | 129.74% |
| 2022-02-17 | 7 | $44 | $35 | $38.8 | $16.83 | 130.54% |
| 2022-03-08 | 7 | $44 | $35 | $38.666 | $16.83 | 129.74% |
| 2022-04-25 | 7 | $44 | $35 | $39.166 | $16.83 | 132.72% |
| 2022-05-05 | 7 | $44 | $35 | $39 | $16.83 | 131.73% |
| 2022-05-23 | 8 | $44 | $35 | $39.142 | $16.83 | 132.57% |
| 2022-06-15 | 7 | $44 | $35 | $39.142 | $16.83 | 132.57% |
| 2022-07-18 | 7 | $44 | $34 | $38.428 | $16.83 | 128.33% |
| 2022-08-01 | 7 | $41 | $34 | $38 | $16.83 | 125.79% |
| 2022-08-19 | 7 | $41 | $35 | $37.714 | $16.83 | 124.09% |
| 2022-09-17 | 7 | $41 | $34 | $37.285 | $16.83 | 121.54% |
| 2022-10-12 | 7 | $41 | $27 | $36.142 | $16.83 | 114.75% |
| 2022-10-14 | 7 | $41 | $25 | $34.428 | $16.83 | 104.56% |
| 2022-11-04 | 7 | $40 | $24 | $33.428 | $16.83 | 98.62% |
| 2023-01-05 | 7 | $40 | $22 | $32.285 | $16.83 | 91.83% |
| 2023-02-13 | 7 | $40 | $24 | $32.571 | $16.83 | 93.53% |
| 2023-02-17 | 7 | $40 | $24 | $32.428 | $16.83 | 92.68% |
| 2023-04-10 | 8 | $40 | $24 | $32.5 | $16.83 | 93.11% |
| 2023-04-18 | 7 | $36 | $24 | $30.142 | $16.83 | 79.1% |
| 2023-05-08 | 5 | $36 | $23 | $29.333 | $16.83 | 74.29% |
| 2023-06-11 | 6 | $36 | $23 | $28.666 | $16.83 | 70.33% |
| 2023-07-11 | 5 | $33 | $23 | $27.2 | $16.83 | 61.62% |
| 2023-07-31 | 5 | $33 | $23 | $26.4 | $16.83 | 56.86% |
| 2023-08-10 | 5 | $33 | $23 | $26.8 | $16.83 | 59.24% |
| 2023-10-02 | 6 | $33 | $23 | $27 | $16.83 | 60.43% |
| 2023-10-11 | 6 | $33 | $22 | $26.166 | $16.83 | 55.47% |
| 2023-10-12 | 6 | $33 | $19 | $25.5 | $16.83 | 51.52% |
| 2023-10-24 | 6 | $32 | $19 | $24.833 | $16.83 | 47.55% |
| 2023-11-03 | 7 | $32 | $11 | $22 | $16.83 | 30.72% |
| 2023-11-06 | 7 | $32 | $11 | $20.714 | $16.83 | 23.08% |
| 2023-11-07 | 7 | $32 | $11 | $20.285 | $16.83 | 20.53% |
| 2023-12-17 | 7 | $27 | $11 | $18.857 | $16.83 | 12.04% |
The Trend in the Analyst Price Target
OGN's average price target has moved down $15.57 over the prior 14 months.
Over the past 48 weeks, OGN's average upside potential has been 37.95%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-18 | 5 | 36 | 24 | 29.666 | 23.59 | 25.76% |
| 2023-04-18 | 8 | 36 | 24 | 29.666 | 23.59 | 25.76% |
| 2023-07-31 | 5 | 33 | 23 | 26.400 | 21.98 | 20.11% |
| 2023-09-21 | 6 | 33 | 23 | 27.000 | 18.58 | 45.32% |
| 2023-10-02 | 6 | 33 | 23 | 27.000 | 16.69 | 61.77% |
OGN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.57 | 2 | 0 | 4 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
OGN's average broker recommendation rating worsened by 0.07 over the prior 31 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ORGANON & CO's upside potential (average analyst target price relative to current price) is greater than 2997.04% of all US stocks.
- In terms of how ORGANON & CO fares relative to all US stocks, note that its number of analysts covering the stock is higher than 1290.46% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ORGANON & CO's variance in analysts' estimates is lower than -988.06% of them.
- ORGANON & CO's average analyst price target is greater than 1802.39% of stocks in the mid market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ORGANON & CO are LYEL, VERV, and ATAI.
View All Top Stocks by Price Target
What is the outlook for OGN? Use POWR Ratings for clearer insight into price direction.